Showing results (51-60 of 366) with videos related to
Sort By:
Pageof 37
American Journal on Intellectual and Developmental Disabilities|December 27, 2019
Adverse Medication Events Related to Hospitalization in the United States: A Comparison Between Adults With Intellectual and Developmental Disabilities and Those WithoutSteven R Erickson, Neil Kamdar, Chung-Hsuen WuIntellectual and Developmental Disabilities|November 29, 2016
Issues in the Medication Management Process in People Who Have Intellectual and Developmental Disabilities: A Qualitative Study of the Caregivers' PerspectiveSteven R Erickson, Teresa M Salgado, Xi TanFrontiers in Psychiatry|November 29, 2023
Risk of post-fracture pneumonia and its association with cardiovascular events and mortality in adults with intellectual disabilitiesDaniel G Whitney, Steven R Erickson, Maryam BerriCurrent Cancer Drug Targets|October 8, 2003
The clinical applications of heat shock protein inhibitors in cancer - present and futureUdai Banerji, Ian Judson, Paul WorkmanCancer Cell|February 28, 2025
Probing cancer with small-molecule tools-Progress and challengesSusanne Müller, Domenico Sanfelice, Paul WorkmanCurrent Topics in Medicinal Chemistry|July 18, 2006
Inhibitors of the HSP90 molecular chaperone: attacking the master regulator in cancerEdward McDonald, Paul Workman, Keith JonesBiomarkers in Medicine|May 19, 2010
Use of pharmacokinetic/pharmacodynamic biomarkers to support rational cancer drug developmentDebashis Sarker, Simon Pacey, Paul WorkmanDrug Discovery Today|January 17, 2012
HSP90 inhibition: two-pronged exploitation of cancer dependenciesJon Travers, Swee Sharp, Paul WorkmanInternational Journal of Cardiology|July 13, 2016
Cardiovascular risk and treatment for adults with intellectual or developmental disabilitiesSteven R Erickson, Patrick Spoutz, Michael Dorsch, et al.ERJ Open Research|February 25, 2026
Mirror, mirror on the wall: is CompEx the fairest endpoint of all?Chun-Tse Hung, Steven R Erickson, Chung-Hsuen WuPageof 37